Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycosphingolipidoses: beyond the enzymatic defect.

Annick Raas-Rothschild1, Irene Pankova-Kholmyansky, Yaacov Kacher

  • 1Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel.

Glycoconjugate Journal
|October 30, 2004
PubMed
Summary

Glycosphingolipid lysosomal storage diseases are genetic disorders impacting enzyme function. This review explores their varied symptoms and links pathology to altered biochemical pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

It's time to rethink academic innovation: why technology transfer offices can't do it alone.

Nature biotechnology·2026
Same author

Discovery of a potential CERS2 inhibitor: hit compound identification via structure-based virtual screening and molecular dynamics simulations.

Molecular diversity·2026
Same author

Nucleolin perturbation alters membrane lipid homeostasis.

Molecular omics·2025
Same author

Ultrafast Measurement of Circulating Ceramides in Human Cohorts.

Analytical chemistry·2025
Same author

Deep sphingolipidomic and metabolomic analyses of ceramide synthase 2 null mice reveal complex pathway-specific effects.

Journal of lipid research·2025
Same author

Reduced circulating sphingolipids and <i>CERS2</i> activity are linked to T2D risk and impaired insulin secretion.

Science advances·2025

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Glycosphingolipid lysosomal storage diseases (GLSDs) are monogenic human disorders.
  • These conditions arise from impaired enzyme activity in glycosphingolipid catabolism.
  • GLSDs exhibit heterogeneous clinical presentations with unclear genotype-phenotype correlations.

Purpose of the Study:

  • To review the clinical symptoms of GLSDs.
  • To correlate disease progression and pathogenesis with altered biochemical and cellular pathways.

Main Methods:

  • Literature review of clinical presentations.
  • Analysis of biochemical and cellular pathways involved in glycosphingolipid metabolism.
  • Correlation of clinical data with molecular mechanisms.

Related Experiment Videos

Main Results:

  • GLSDs present with diverse clinical manifestations.
  • Accumulation of specific glycosphingolipids does not clearly predict disease severity or progression.
  • Altered enzymatic activity impacts cellular function and disease pathology.

Conclusions:

  • Understanding the link between biochemical alterations and clinical outcomes is crucial for managing GLSDs.
  • Further research into specific pathways may reveal therapeutic targets.
  • Despite heterogeneity, a common theme of impaired glycosphingolipid catabolism underlies these disorders.